High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy

High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy

Abstract Background Ovarian carcinoma (OC) is the fifth most common female cancer and mostly diagnosed at an advanced stage. Surgical debulking is usually followed by adjuvant platinum-based chemotherapy. Only few biomarkers are known to be related to chemosensitivity. OX40 is a TNF receptor member...

Full description

Bibliographic Details
Main Authors: Michaela Ramser, Simone Eichelberger, Silvio Däster, Benjamin Weixler, Marko Kraljević, Robert Mechera, Athanasios Tampakis, Tarik Delko, Uwe Güth, Sylvia Stadlmann, Luigi Terracciano, Raoul A. Droeser, Gad Singer
Format: Article
Language:English
Published: BMC 2018-04-01
Series:BMC Cancer
Subjects:
OX40
CD134
Ovarian cancer
Chemosensitivity
Online Access:http://link.springer.com/article/10.1186/s12885-018-4339-0

Internet

http://link.springer.com/article/10.1186/s12885-018-4339-0

Similar Items